These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38561692)

  • 1. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
    Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R
    J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tau protein elevation in migraine: a cross-sectional case-control study.
    Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
    J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.
    Schulz I; Kruse N; Gera RG; Kremer T; Cedarbaum J; Barbour R; Zago W; Schade S; Otte B; Bartl M; Hutten SJ; Trenkwalder C; Mollenhauer B
    Mov Disord; 2021 Dec; 36(12):2874-2887. PubMed ID: 34363416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis.
    Piel JHA; Bargemann L; Leypoldt F; Wandinger KP; Dargvainiene J
    Front Neurol; 2024; 15():1356575. PubMed ID: 38566855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
    Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N
    Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay.
    Asken BM; Yang Z; Xu H; Weber AG; Hayes RL; Bauer RM; DeKosky ST; Jaffee MS; Wang KKW; Clugston JR
    J Neurotrauma; 2020 Jul; 37(13):1537-1545. PubMed ID: 32024456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
    Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
    Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
    Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
    Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.
    Carta S; Dinoto A; Capobianco M; Valentino P; Montarolo F; Sala A; Reindl M; Lo Re M; Chiodega V; Branger P; Audoin B; Aboab J; Papeix C; Collongues N; Kerschen P; Zephir H; Créange A; Bourre B; Schanda K; Flanagan EP; Redenbaugh V; Villacieros-Álvarez J; Arrambide G; Cobo-Calvo A; Ferrari S; Marignier R; Mariotto S
    Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):e200188. PubMed ID: 38134369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Factors Influencing Baseline Plasma Biomarkers for Sport-Related Concussion in Adolescents.
    Tabor JB; Penner LC; Cooper JG; Ghodsi M; Galarneau JM; Fraser DD; Emery CA; Wellington CL; Debert CT
    J Neurotrauma; 2023 Aug; 40(15-16):1638-1650. PubMed ID: 36852497
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
    Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
    Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
    Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage.
    Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C
    Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
    Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
    Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.